We’ve reissued two notices of funding opportunities (NOFOs) for our Technology Development Programs:
Technology Development Research for Establishing Feasibility and Proof of Concept (R21 Clinical Trial Not Allowed) PAR-25-202
This NOFO solicits R21 applications with innovative, high-risk concepts for developing new technologies or radically improving existing ones. It supports novel concepts that haven’t been tested for feasibility. Because inclusion of unpublished or preliminary data isn’t allowed under this NOFO, NIGMS expects the proposed projects to be high risk.
Continue reading “NIGMS Funding Opportunities for Technology Development”